Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Giant Cell Tumor of the Tendon Sheath”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Testing effectiveness (Phase 2)Ended earlyNCT04938180
What this trial is testing

Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients

Who this might be right for
Tenosynovial Giant Cell TumorPigmented Villonodular SynovitisTGCT+1 more
AmMax Bio, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT04731675
What this trial is testing

An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee

Who this might be right for
Tenosynovial Giant Cell TumorPigmented Villonodular Synovitis (PVNS)
AmMax Bio, Inc. 11
Large-scale testing (Phase 3)Active Not RecruitingNCT05059262
What this trial is testing

Study of Vimseltinib for Tenosynovial Giant Cell Tumor

Who this might be right for
Tenosynovial Giant Cell TumorPigmented Villonodular SynovitisGiant Cell Tumor of Tendon Sheath+2 more
Deciphera Pharmaceuticals, LLC 123
Large-scale testing (Phase 3)Active Not RecruitingNCT05417789
What this trial is testing

Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

Who this might be right for
TGCT
SynOx Therapeutics Limited 128
Very early researchStudy completedNCT04223635
What this trial is testing

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

Who this might be right for
Moderate Hepatic Impairment
Daiichi Sankyo 16
Early research (Phase 1)Study completedNCT03291288
What this trial is testing

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Who this might be right for
Drug Interaction Potential
Daiichi Sankyo 32
Not applicableStudy completedNCT04952896
What this trial is testing

Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease

Who this might be right for
Synovial DiseasesPigmented Villonodular SynovitisGout+1 more
Peking University Third Hospital 350
Testing effectiveness (Phase 2)Looking for participantsNCT07499362
What this trial is testing

Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)

Who this might be right for
Tenosynovial Giant Cell Tumor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 20
Post-approval studies (Phase 4)Looking for participantsNCT07315841
What this trial is testing

Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery

Who this might be right for
Tenosynovial Giant Cell Tumor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04488822
What this trial is testing

The Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT

Who this might be right for
Tenosynovial Giant Cell Tumor
Daiichi Sankyo Co., Ltd. 40
Not applicableLooking for participantsNCT07503821
What this trial is testing

Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis

Who this might be right for
Synovitis Villonodular
Nantes University Hospital 30
Not applicableLooking for participantsNCT04635111
What this trial is testing

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

Who this might be right for
HepatotoxicityTenosynovial Giant Cell Tumor
Daiichi Sankyo 30
Testing effectiveness (Phase 2)Study completedNCT05349643
What this trial is testing

Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Who this might be right for
Pigmented Villonodular SynovitisTGCTTenosynovial Giant Cell Tumor
AmMax Bio, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT01207492
What this trial is testing

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

Who this might be right for
Pigmented Villonodular SynovitisDiffuse-type Giant Cell TumorTenosynovial Giant Cell Tumor
Andrew J. Wagner, MD, PhD 17
Large-scale testing (Phase 3)Study completedNCT02371369
What this trial is testing

Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)

Who this might be right for
Pigmented Villonodular SynovitisGiant Cell Tumors of the Tendon SheathTenosynovial Giant Cell Tumor
Daiichi Sankyo 120
Early research (Phase 1)UnknownNCT05212896
What this trial is testing

An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors (Including GCTTS)
Dragonboat Biopharmaceutical Company Limited 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07832747
What this trial is testing

DCC-3014 to Evaluate the Efficacy, Safety, and Pharmacokinetics in Subjects With TGCT

Who this might be right for
Tenosynovial Giant Cell Tumor
Ono Pharmaceutical Co., Ltd. 18
Early research (Phase 1)Looking for participantsNCT04192344
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

Who this might be right for
NeoplasmsTenosynovial Giant Cell Tumor
Abbisko Therapeutics Co, Ltd 276
Testing effectiveness (Phase 2)Study completedNCT01643850
What this trial is testing

MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)

Who this might be right for
Pigmented Villonodular SynovitisPVNSGiant Cell Tumor of the Tendon Sheath+3 more
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT03069469
What this trial is testing

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Who this might be right for
Advanced Malignant NeoplasmPigmented Villonodular SynovitisGiant Cell Tumor of Tendon Sheath+2 more
Deciphera Pharmaceuticals, LLC 120
Next Page